Shree Ganesh Bio-Tech (India) has informed that Outcome of the Board Meeting of the Company held on Monday 23rd May 2022 in accordance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 has been approved by the Board of Directors of the Company and taken on record the following items: Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2022 and Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2022. Further, the company declared that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2022 with unmodified opinion.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Venkys India | 1524.55 |
| Mangalam Global Ent | 13.87 |
| Kaveri Seed | 938.40 |
| Regaal Resources | 83.72 |
| Simran Farms | 160.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: